<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38289118</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.</ArticleTitle><Pagination><StartPage>e0190923</StartPage><MedlinePgn>e0190923</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01909-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01909-23</ELocationID><Abstract><AbstractText>Pyroptosis, a pro-inflammatory programmed cell death, has been implicated in the pathogenesis of coronavirus disease 2019 and other viral diseases. Gasdermin family proteins (GSDMs), including GSDMD and GSDME, are key regulators of pyroptotic cell death. However, the mechanisms by which virus infection modulates pyroptosis remain unclear. Here, we employed a mCherry-GSDMD fluorescent reporter assay to screen for viral proteins that impede the localization and function of GSDMD in living cells. Our data indicated that the main protease NSP5 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) blocked GSDMD-mediated pyroptosis via cleaving residues Q29 and Q193 of GSDMD. While another SARS-CoV-2 protease, NSP3, cleaved GSDME at residue G370 but activated GSDME-mediated pyroptosis. Interestingly, respiratory enterovirus EV-D68-encoded proteases 3C and 2A also exhibit similar differential regulation on the functions of GSDMs by inactivating GSDMD but initiating GSDME-mediated pyroptosis. EV-D68 infection exerted oncolytic effects on human cancer cells by inducing pyroptotic cell death. Our findings provide insights into how respiratory viruses manipulate host cell pyroptosis and suggest potential targets for antiviral therapy as well as cancer treatment.IMPORTANCEPyroptosis plays a crucial role in the pathogenesis of coronavirus disease 2019, and comprehending its function may facilitate the development of novel therapeutic strategies. This study aims to explore how viral-encoded proteases modulate pyroptosis. We investigated the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory enterovirus D68 (EV-D68) proteases on host cell pyroptosis. We found that SARS-CoV-2-encoded proteases NSP5 and NSP3 inactivate gasdermin D (GSDMD) but initiate gasdermin E (GSDME)-mediated pyroptosis, respectively. We also discovered that another respiratory virus EV-D68 encodes two distinct proteases 2A and 3C that selectively trigger GSDME-mediated pyroptosis while suppressing the function of GSDMD. Based on these findings, we further noted that EV-D68 infection triggers pyroptosis and produces oncolytic effects in human carcinoma cells. Our study provides new insights into the molecular mechanisms underlying virus-modulated pyroptosis and identifies potential targets for the development of antiviral and cancer therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5886-7235</Identifier><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Haoran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yubin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Pei-Hui</ForeName><Initials>P-H</Initials><AffiliationInfo><Affiliation>Key Laboratory for Experimental Teratology of Ministry of Education, Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xiao-Fang</ForeName><Initials>X-F</Initials><AffiliationInfo><Affiliation>Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4456-840X</Identifier><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Translational Medicine, First Hospital, Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32222005</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>82172246</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>2018ZX10731-101-001-016</GrantID><Agency>National Major Project for Infectious Disease Control and Prevention</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C000706209">3C-like proteinase, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000094524">Gasdermins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498366">GSDMD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.2</RegistryNumber><NameOfSubstance UI="C000706267">papain-like protease, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="Y">Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094524" MajorTopicYN="N">Gasdermins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="Y">Host Microbial Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050130" MajorTopicYN="N">Oncolytic Virotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050504" MajorTopicYN="Y">Oncolytic Viruses</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069292" MajorTopicYN="Y">Pyroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-D68</Keyword><Keyword MajorTopicYN="N">GSDMD</Keyword><Keyword MajorTopicYN="N">GSDME</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">pyroptosis</Keyword><Keyword MajorTopicYN="N">viral protease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38289118</ArticleId><ArticleId IdType="pmc">PMC10878271</ArticleId><ArticleId IdType="doi">10.1128/jvi.01909-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative . 2022. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400:452–461. doi:10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost J, Rudy MJ, Leser JS, Tan H, Hu Y, Wang J, Clarke P, Tyler KL. 2023. Telaprevir treatment reduces paralysis in a mouse model of enterovirus D68 acute flaccid myelitis. J Virol 97:e0015623. doi:10.1128/jvi.00156-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00156-23</ArticleId><ArticleId IdType="pmc">PMC10231134</ArticleId><ArticleId IdType="pubmed">37154751</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedson DS. 2018. Influenza, evolution, and the next pandemic. Evol Med Public Health 2018:260–269. doi:10.1093/emph/eoy027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emph/eoy027</ArticleId><ArticleId IdType="pmc">PMC6234328</ArticleId><ArticleId IdType="pubmed">30455951</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey ES, Choi JY, Fieldhouse JK, Borkenhagen LK, Zemke J, Zhang D, Gray GC. 2018. The continual threat of influenza virus infections at the human-animal interface: what is new from a one health perspective?. Evol Med Public Health 2018:192–198. doi:10.1093/emph/eoy013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emph/eoy013</ArticleId><ArticleId IdType="pmc">PMC6128238</ArticleId><ArticleId IdType="pubmed">30210800</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, et al. . 2022. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 399:2047–2064. doi:10.1016/S0140-6736(22)00478-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00478-0</ArticleId><ArticleId IdType="pmc">PMC7613574</ArticleId><ArticleId IdType="pubmed">35598608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liu Q, Guo D. 2020. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418–423. doi:10.1002/jmv.25681</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25681</ArticleId><ArticleId IdType="pmc">PMC7167049</ArticleId><ArticleId IdType="pubmed">31967327</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Rao Z. 2021. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol 19:685–700. doi:10.1038/s41579-021-00630-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00630-8</ArticleId><ArticleId IdType="pmc">PMC8447893</ArticleId><ArticleId IdType="pubmed">34535791</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Muruato A, Lokugamage KG, Narayanan K, Zhang X, Zou J, Liu J, Schindewolf C, Bopp NE, Aguilar PV, Plante KS, Weaver SC, Makino S, LeDuc JW, Menachery VD, Shi PY. 2020. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27:841–848. doi:10.1016/j.chom.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7153529</ArticleId><ArticleId IdType="pubmed">32289263</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone B, Urakova N, Snijder EJ, Campbell EA. 2022. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. Nat Rev Mol Cell Biol 23:21–39. doi:10.1038/s41580-021-00432-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00432-z</ArticleId><ArticleId IdType="pmc">PMC8613731</ArticleId><ArticleId IdType="pubmed">34824452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. 2020. A new coronavirus associated with human respiratory disease in China. Nature 579:265–269. doi:10.1038/s41586-020-2008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustaqil M, Ollivier E, Chiu H-P, Van Tol S, Rudolffi-Soto P, Stevens C, Bhumkar A, Hunter DJB, Freiberg AN, Jacques D, Lee B, Sierecki E, Gambin Y. 2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species. Emerg Microbes Infect 10:178–195. doi:10.1080/22221751.2020.1870414</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1870414</ArticleId><ArticleId IdType="pmc">PMC7850364</ArticleId><ArticleId IdType="pubmed">33372854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Cruz-Cosme R, Zhuang MW, Liu D, Liu Y, Teng S, Wang PH, Tang Q. 2020. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins. Signal Transduct Target Ther 5:269. doi:10.1038/s41392-020-00372-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00372-8</ArticleId><ArticleId IdType="pmc">PMC7670843</ArticleId><ArticleId IdType="pubmed">33203855</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. 2022. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23:3–20. doi:10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, Fokine A, Meng G, Shin WH, Long F, Kuhn RJ, Kihara D, Rossmann MG. 2015. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 347:71–74. doi:10.1126/science.1261962</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1261962</ArticleId><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L, Essaidi-Laziosi M, Pérez-Rodríguez FJ, Piuz I, Geiser J, Krause KH, Huang S, Constant S, Kaiser L, Garcin D, Tapparel C. 2018. Viral chimeras decrypt the role of enterovirus capsid proteins in viral tropism, acid sensitivity and optimal growth temperature. PLoS Pathog 14:e1006962. doi:10.1371/journal.ppat.1006962</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006962</ArticleId><ArticleId IdType="pmc">PMC5908207</ArticleId><ArticleId IdType="pubmed">29630666</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Li Y, Liu G, Jiang Y, Shen S, Bi R, Huang H, Cheng T, Wang C, Wei W. 2019. A second open reading frame in human enterovirus determines viral replication in intestinal epithelial cells. Nat Commun 10:4066. doi:10.1038/s41467-019-12040-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12040-9</ArticleId><ArticleId IdType="pmc">PMC6731315</ArticleId><ArticleId IdType="pubmed">31492846</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L, Tapparel C. 2016. Rhinoviruses and respiratory enteroviruses: not as simple as ABC. Viruses 8:16. doi:10.3390/v8010016</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010016</ArticleId><ArticleId IdType="pmc">PMC4728576</ArticleId><ArticleId IdType="pubmed">26761027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Clarke P, Tyler KL. 2019. Contemporary circulating enterovirus D68 strains infect and undergo retrograde axonal transport in spinal motor neurons independent of sialic acid. J Virol 93:e00578-19. doi:10.1128/JVI.00578-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00578-19</ArticleId><ArticleId IdType="pmc">PMC6675884</ArticleId><ArticleId IdType="pubmed">31167912</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Shih SR. 2015. Neurotropic enterovirus infections in the central nervous system. Viruses 7:6051–6066. doi:10.3390/v7112920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112920</ArticleId><ArticleId IdType="pmc">PMC4664993</ArticleId><ArticleId IdType="pubmed">26610549</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Liu S, Shen S, Guo H, Huang H, Wei W. 2020. Methyl-β-cyclodextrin inhibits EV-D68 virus entry by perturbing the accumulation of virus particles and ICAM-5 in lipid rafts. Antiviral Res 176:104752. doi:10.1016/j.antiviral.2020.104752</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104752</ArticleId><ArticleId IdType="pubmed">32101770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S, Anderson CW, Wimmer E. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291:547–553. doi:10.1038/291547a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/291547a0</ArticleId><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello VR, Baltimore D. 1981a. Cloned Poliovirus complementary DNA is infectious in mammalian cells. Science 214:916–919. doi:10.1126/science.6272391</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6272391</ArticleId><ArticleId IdType="pubmed">6272391</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello VR, Baltimore D. 1981. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A 78:4887–4891. doi:10.1073/pnas.78.8.4887</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.78.8.4887</ArticleId><ArticleId IdType="pmc">PMC320284</ArticleId><ArticleId IdType="pubmed">6272282</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating J, van Kuppeveld FJM. 2018. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368–381. doi:10.1038/s41579-018-0005-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, Baggen J, Meng G, Xiao C, Thibaut HJ, van Kuppeveld FJM, Rossmann MG. 2015. Sialic acid-dependent cell entry of human enterovirus D68. Nat Commun 6:8865. doi:10.1038/ncomms9865</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9865</ArticleId><ArticleId IdType="pmc">PMC4660200</ArticleId><ArticleId IdType="pubmed">26563423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar A, Depla JA, Mulder LA, Karelehto E, Brouwer L, Kruiswijk L, Vieira de Sá R, Meijer A, Evers MM, van Kuppeveld FJM, Pajkrt D, Wolthers KC, Gu H. 2022. Enterovirus D68 infection in human primary airway and brain organoids: no additional role for heparan sulfate binding for neurotropism. Microbiol Spectr 10:e0169422. doi:10.1128/spectrum.01694-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01694-22</ArticleId><ArticleId IdType="pmc">PMC9603061</ArticleId><ArticleId IdType="pubmed">36154279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Guo H, Chang J, Yu Y, Liu G, Zhang N, Willard SH, Zheng S, Yu XF. 2016. ICAM-5/Telencephalin is a functional entry receptor for enterovirus D68. Cell Host Microbe 20:631–641. doi:10.1016/j.chom.2016.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.09.013</ArticleId><ArticleId IdType="pubmed">27923705</ArticleId></ArticleIdList></Reference><Reference><Citation>Koupenova M, Corkrey HA, Vitseva O, Tanriverdi K, Somasundaran M, Liu P, Soofi S, Bhandari R, Godwin M, Parsi KM, Cousineau A, Maehr R, Wang JP, Cameron SJ, Rade J, Finberg RW, Freedman JE. 2021. SARS-CoV-2 initiates programmed cell death in platelets. Circ Res 129:631–646. doi:10.1161/CIRCRESAHA.121.319117</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319117</ArticleId><ArticleId IdType="pmc">PMC8409903</ArticleId><ArticleId IdType="pubmed">34293929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Yu J, Wong SH, Chan MTV, Zhang L, Wu WKK. 2022. SARS-CoV-2 targets the lysosome to mediate airway inflammatory cell death. Autophagy 18:2246–2248. doi:10.1080/15548627.2021.2021496</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.2021496</ArticleId><ArticleId IdType="pmc">PMC9397439</ArticleId><ArticleId IdType="pubmed">35067165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yang J, Li H, Zhang Z, Ji Z, Zhao L, Wei W, Dutch RE. 2023. Enterovirus D68 infection induces TDP-43 cleavage, aggregation, and neurotoxicity. J Virol 97:e0042523. doi:10.1128/jvi.00425-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00425-23</ArticleId><ArticleId IdType="pmc">PMC10134869</ArticleId><ArticleId IdType="pubmed">37039659</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll RC, Schroder K, Pelegrín P. 2022. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci 43:653–668. doi:10.1016/j.tips.2022.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2022.04.003</ArticleId><ArticleId IdType="pubmed">35513901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, Sun H, Wang DC, Shao F. 2016. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535:111–116. doi:10.1038/nature18590</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18590</ArticleId><ArticleId IdType="pubmed">27281216</ArticleId></ArticleIdList></Reference><Reference><Citation>Vora SM, Lieberman J, Wu H. 2021. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 21:694–703. doi:10.1038/s41577-021-00588-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00588-x</ArticleId><ArticleId IdType="pmc">PMC8351223</ArticleId><ArticleId IdType="pubmed">34373622</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Deng W, Bai Y, Miao R, Mei S, Zhang Z, Pan Y, Wang Y, Min R, Deng F, Wu Z, Li W, Chen P, Ma T, Lou X, Lieberman J, Liu X. 2021. The lysosomal Rag-Ragulator complex licenses RIPK1– and caspase-8–mediated pyroptosis by Yersinia. Science 372:eabg0269. doi:10.1126/science.abg0269</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg0269</ArticleId><ArticleId IdType="pmc">PMC8769499</ArticleId><ArticleId IdType="pubmed">35058659</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, Shao F, Wu K, Liang J. 2018. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol 68:773–782. doi:10.1016/j.jhep.2017.11.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2017.11.040</ArticleId><ArticleId IdType="pubmed">29273476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, Brewer JR, Han A, Steach HR, Israelow B, Blackburn HN, Velazquez SE, Chen YG, Halene S, Iwasaki A, Meffre E, Nussenzweig M, Lieberman J, Wilen CB, Kluger Y, Flavell RA. 2022. Inflammasome activation in infected Macrophages drives COVID-19 pathology. Nature 606:585–593. doi:10.1038/s41586-022-04802-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04802-1</ArticleId><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Boal-Carvalho I, Mazel-Sanchez B, Silva F, Garnier L, Yildiz S, Bonifacio JP, Niu C, Williams N, Francois P, Schwerk N, Schöning J, Carlens J, Viemann D, Hugues S, Schmolke M. 2020. Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages. EMBO Rep 21:e50421. doi:10.15252/embr.202050421</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202050421</ArticleId><ArticleId IdType="pmc">PMC7726813</ArticleId><ArticleId IdType="pubmed">33180976</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanova E, Wu R, Wang W, Yan R, Chen Y, French SW, Llorente C, Pan SQ, Yang Q, Li Y, Lazaro R, Ansong C, Smith RD, Bataller R, Morgan T, Schnabl B, Tsukamoto H. 2018. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737–1753. doi:10.1002/hep.29645</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.29645</ArticleId><ArticleId IdType="pmc">PMC5906140</ArticleId><ArticleId IdType="pubmed">29108122</ArticleId></ArticleIdList></Reference><Reference><Citation>Doitsh G, Galloway NLK, Geng X, Yang Z, Monroe KM, Zepeda O, Hunt PW, Hatano H, Sowinski S, Muñoz-Arias I, Greene WC. 2014. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505:509–514. doi:10.1038/nature12940</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12940</ArticleId><ArticleId IdType="pmc">PMC4047036</ArticleId><ArticleId IdType="pubmed">24356306</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson KS, Teo DET, Tan KS, Toh GA, Ong HH, Lim CK, Lay K, Au BV, Lew TS, Chu JJH, Chow VTK, Wang DY, Zhong FL, Reversade B. 2020. Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia. Science 370:eaay2002. doi:10.1126/science.aay2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay2002</ArticleId><ArticleId IdType="pubmed">33093214</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira C, Crespo Â, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, et al. . 2022. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606:576–584. doi:10.1038/s41586-022-04702-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04702-4</ArticleId><ArticleId IdType="pmc">PMC10071495</ArticleId><ArticleId IdType="pubmed">35385861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittner ZA, Schrader M, George SE, Amann R. 2022. Pyroptosis and its role in SARS-CoV-2 infection. Cells 11:1717. doi:10.3390/cells11101717</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11101717</ArticleId><ArticleId IdType="pmc">PMC9140030</ArticleId><ArticleId IdType="pubmed">35626754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Zhu F, Zhao M, Shao F, Yu D, Ma J, Zhang X, Li W, Qian Y, Zhang Y, Jiang D, Wang S, Xia P. 2021. SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage. EMBO J 40:e108249. doi:10.15252/embj.2021108249</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108249</ArticleId><ArticleId IdType="pmc">PMC8420271</ArticleId><ArticleId IdType="pubmed">34296442</ArticleId></ArticleIdList></Reference><Reference><Citation>Planès R, Pinilla M, Santoni K, Hessel A, Passemar C, Lay K, Paillette P, Valadão A-LC, Robinson KS, Bastard P, et al. . 2022. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. Mol Cell 82:2385–2400. doi:10.1016/j.molcel.2022.04.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.04.033</ArticleId><ArticleId IdType="pmc">PMC9108100</ArticleId><ArticleId IdType="pubmed">35594856</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, Huang C, Chen J, Zhi F. 2020. HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway. J Hematol Oncol 13:149. doi:10.1186/s13045-020-00985-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00985-0</ArticleId><ArticleId IdType="pmc">PMC7648939</ArticleId><ArticleId IdType="pubmed">33160389</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Yi M, Tan Y, Li X, Li G, Zeng Z, Xiong W, Xiang B. 2021. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ. J Exp Clin Cancer Res 40:190. doi:10.1186/s13046-021-01995-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-021-01995-7</ArticleId><ArticleId IdType="pmc">PMC8188724</ArticleId><ArticleId IdType="pubmed">34108030</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Li Y, Zhu Y, Li N, Li W, Shang C, Song G, Li S, Cong J, Li T, Xiu Z, Lu J, Ge C, Yang X, Li Y, Sun L, Li X, Jin N. 2022. Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. Int J Biol Sci 18:717–730. doi:10.7150/ijbs.64350</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.64350</ArticleId><ArticleId IdType="pmc">PMC8741846</ArticleId><ArticleId IdType="pubmed">35002520</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P, Shen M, Yu Z, Ge W, Chen K, Tian M, Xiao F, Wang Z, Wang J, Jia Y, Wang W, Wan P, Zhang J, Chen W, Lei Z, Chen X, Luo Z, Zhang Q, Xu M, Li G, Li Y, Wu J. 2021. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat Commun 12:4664. doi:10.1038/s41467-021-25015-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25015-6</ArticleId><ArticleId IdType="pmc">PMC8329225</ArticleId><ArticleId IdType="pubmed">34341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. 2021. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597:415–419. doi:10.1038/s41586-021-03875-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03875-8</ArticleId><ArticleId IdType="pmc">PMC8603942</ArticleId><ArticleId IdType="pubmed">34471287</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdonck S, Nemegeer J, Vandenabeele P, Maelfait J. 2022. Viral manipulation of host cell necroptosis and pyroptosis. Trends Microbiol 30:593–605. doi:10.1016/j.tim.2021.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.11.011</ArticleId><ArticleId IdType="pubmed">34933805</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD. 2021. Synergism of TNF-α and IFN-γ triggers Inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndrome. Cell 184:149–168. doi:10.1016/j.cell.2020.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7674074</ArticleId><ArticleId IdType="pubmed">33278357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Li J, Wang Y, Yu X, He X, Shi J, Deng G, Zeng X, Tian G, Li Y, Jiang Y, Guan Y, Li C, Shao F, Chen H. 2022. H7N9 virus infection triggers lethal cytokine storm by activating gasdermin E-mediated pyroptosis of lung alveolar epithelial cells. Natl Sci Rev 9:nwab137. doi:10.1093/nsr/nwab137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwab137</ArticleId><ArticleId IdType="pmc">PMC8788236</ArticleId><ArticleId IdType="pubmed">35087672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Yu XF. 2015. HIV-1/HIV-2 versus SAMHD1 restriction: a tale of two viruses. Cell Host Microbe 17:8–9. doi:10.1016/j.chom.2014.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.12.005</ArticleId><ArticleId IdType="pubmed">25590755</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid F, Xie Z, Suleman M, Shah A, Khan S, Luo S. 2022. Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front Immunol 13:940756. doi:10.3389/fimmu.2022.940756</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.940756</ArticleId><ArticleId IdType="pmc">PMC9394213</ArticleId><ArticleId IdType="pubmed">36003396</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Li Y, Wang S, Li H, Zhang L, Zhang H, Wang PH, Zheng X, Yu XF, Wei W. 2023. The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates. Signal Transduct Target Ther 8:109. doi:10.1038/s41392-023-01386-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01386-8</ArticleId><ArticleId IdType="pmc">PMC9998009</ArticleId><ArticleId IdType="pubmed">36894543</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B, Joyce R, Tan H, Hu Y, Wang J. 2023. SARS-CoV-2 main protease drug design, assay development, and drug resistance studies. Acc Chem Res 56:157–168. doi:10.1021/acs.accounts.2c00735</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.accounts.2c00735</ArticleId><ArticleId IdType="pmc">PMC9843634</ArticleId><ArticleId IdType="pubmed">36580641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Wang Y, Lin L, Si X, Wang T, Zhong X, Tong L, Luan Y, Chen Y, Li X, Zhang F, Zhao W, Zhong Z. 2014. Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections. Virol J 11:192. doi:10.1186/s12985-014-0192-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-014-0192-1</ArticleId><ArticleId IdType="pmc">PMC4247557</ArticleId><ArticleId IdType="pubmed">25410318</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Hu Z, Fan S, Zhang Q, Zhong Y, Guo D, Qin Y, Chen M, Sarnow P. 2018. Picornavirus 2A protease regulates stress granule formation to facilitate viral translation. PLoS Pathog 14:e1006901. doi:10.1371/journal.ppat.1006901</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006901</ArticleId><ArticleId IdType="pmc">PMC5819834</ArticleId><ArticleId IdType="pubmed">29415027</ArticleId></ArticleIdList></Reference><Reference><Citation>Orzalli MH, Prochera A, Payne L, Smith A, Garlick JA, Kagan JC. 2021. Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. Immunity 54:1447–1462. doi:10.1016/j.immuni.2021.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.012</ArticleId><ArticleId IdType="pmc">PMC8594743</ArticleId><ArticleId IdType="pubmed">33979579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Zhang Z, Xiao X, Qi J, He B, Wang J. 2017. Enterovirus 71 inhibits pyroptosis through cleavage of Gasdermin D. J Virol 91:e01069-17. doi:10.1128/JVI.01069-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01069-17</ArticleId><ArticleId IdType="pmc">PMC5571240</ArticleId><ArticleId IdType="pubmed">28679757</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi F, Lv Q, Wang T, Xu J, Xu W, Shi Y, Fu X, Yang T, Yang Y, Zhuang L, Fang W, Gu J, Li X, Frieman MB, Coyne CB. 2022. Coronaviruses Nsp5 antagonizes porcine gasdermin D-mediated pyroptosis by cleaving pore-forming P30 fragment. mBio 13:e0273921. doi:10.1128/mbio.02739-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02739-21</ArticleId><ArticleId IdType="pmc">PMC8749417</ArticleId><ArticleId IdType="pubmed">35012343</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526:660–665. doi:10.1038/nature15514</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15514</ArticleId><ArticleId IdType="pubmed">26375003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yu Q, Jiang D, Yu K, Yu W, Chi Z, Chen S, Li M, Yang D, Wang Z, Xu T, Guo X, Zhang K, Fang H, Ye Q, He Y, Zhang X, Wang D. 2022. Epithelial Gasdermin D shapes the host-microbial interface by driving mucus layer formation. Sci Immunol 7:eabk2092. doi:10.1126/sciimmunol.abk2092</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk2092</ArticleId><ArticleId IdType="pubmed">35119941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, Junqueira C, Meza-Sosa KF, Mok TMY, Ansara J, Sengupta S, Yao Y, Wu H, Lieberman J. 2020. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579:415–420. doi:10.1038/s41586-020-2071-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2071-9</ArticleId><ArticleId IdType="pmc">PMC7123794</ArticleId><ArticleId IdType="pubmed">32188940</ArticleId></ArticleIdList></Reference><Reference><Citation>Challenor S, Tucker D. 2021. SARS-CoV-2-induced remission of Hodgkin lymphoma. Br J Haematol 192:415. doi:10.1111/bjh.17116</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17116</ArticleId><ArticleId IdType="pubmed">33386647</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin DH, Gillard A, Van Wieren A, Gomez-Manzano C, Fueyo J. 2022. Remission of liquid tumors and SARS-CoV-2 infection: a literature review. Mol Ther Oncolytics 26:135–140. doi:10.1016/j.omto.2022.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omto.2022.06.006</ArticleId><ArticleId IdType="pmc">PMC9186532</ArticleId><ArticleId IdType="pubmed">35702422</ArticleId></ArticleIdList></Reference><Reference><Citation>Itagaki T, Aoki Y, Matoba Y, Tanaka S, Ikeda T, Mizuta K, Matsuzaki Y. 2018. Clinical characteristics of children infected with enterovirus D68 in an outpatient clinic and the association with bronchial asthma. Infect Dis (Lond) 50:303–312. doi:10.1080/23744235.2017.1400176</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2017.1400176</ArticleId><ArticleId IdType="pubmed">29119851</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster JE, Selvarangan R, Hassan F, Briggs KB, Hays L, Miller JO, Pahud B, Puls HT, Queen MA, Thompson MT, Weddle G, Jackson MA. 2017. Clinical course of enterovirus D68 in hospitalized children. Pediatr Infect Dis J 36:290–295. doi:10.1097/INF.0000000000001421</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001421</ArticleId><ArticleId IdType="pubmed">28187115</ArticleId></ArticleIdList></Reference><Reference><Citation>Pixley KV, Falck-Zepeda JB, Giller KE, Glenna LL, Gould F, Mallory-Smith CA, Stelly DM, Stewart CN. 2019. Genome editing, gene drives, and synthetic biology: will they contribute to disease-resistant crops, and who will benefit. Annu Rev Phytopathol 57:165–188. doi:10.1146/annurev-phyto-080417-045954</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-phyto-080417-045954</ArticleId><ArticleId IdType="pubmed">31150590</ArticleId></ArticleIdList></Reference><Reference><Citation>Si L, Shen Q, Li J, Chen L, Shen J, Xiao X, Bai H, Feng T, Ye AY, Li L, et al. . 2022. Generation of a live attenuated influenza A vaccine by proteolysis targeting. Nat Biotechnol 40:1370–1377. doi:10.1038/s41587-022-01381-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01381-4</ArticleId><ArticleId IdType="pubmed">35788567</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>